Composites of ceramic high-temperature proton conductors with inorganic compounds

Schober, T.

doi:10.1149/1.1865592

Journal Article

PreJuSER-45393

Composites of ceramic high-temperature proton conductors with inorganic compounds

Schober, T.FZJ*

2005
Soc. Pennington, NJ

Electrochemical and solid-state letters 8, A199 - A200 (2005) [10.1149/1.1865592]

This record in other databases:

Please use a persistent id in citations: http://hdl.handle.net/2128/2882 doi:10.1149/1.1865592

Abstract: This open-label extension evaluated the long-term efficacy and tolerability of rufinamide in patients with Lennox-Gastaut syndrome (LGS) who had previously completed a 12-week double-blind study.In total, 124 patients (aged 4-37 years), receiving 1-3 concomitant antiepileptic drugs, were treated with rufinamide approximately 25-60 mg/kg/day. Efficacy was assessed by seizure frequency; tolerability by adverse events (AEs) and laboratory tests.Overall, patients were treated with rufinamide for a median (range) of 432 (10-1149) days. Reductions in seizure frequency were observed throughout the study; during the last 12 months of treatment, 41.0% and 47.9% of patients had > or = 50% reduction in total and tonic-atonic seizure frequency, respectively. The most common AEs were vomiting (30.6%) and pyrexia (25.8%).In this open-label extension, rufinamide appeared to be an effective long-term adjunctive therapy for the treatment of LGS-associated seizures in children and young adults.

Keyword(s): J

Classification:

Note: Record converted from VDB: 12.11.2012

Contributing Institute(s):